CEVA INC (CEVA) Stock Fundamental Analysis
NASDAQ:CEVA - Nasdaq - US1572101053 - Common Stock - Currency: USD
Overall CEVA gets a fundamental rating of 5 out of 10. We evaluated CEVA against 110 industry peers in the Semiconductors & Semiconductor Equipment industry. While CEVA has a great health rating, there are worries on its profitability. CEVA is valued quite expensively, but it does show have an excellent growth rating.
1. Profitability
1.1 Basic Checks
CEVA had positive earnings in the past year.
CEVA had a positive operating cash flow in the past year.
CEVA had negative earnings in 4 of the past 5 years.
Of the past 5 years CEVA 4 years had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of -2.15%, CEVA is doing worse than 62.73% of the companies in the same industry.
With a Return On Equity value of -2.48%, CEVA perfoms like the industry average, outperforming 41.82% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.15% | ||
| ROE | -2.48% | ||
| ROIC | N/A |
ROA(3y)-4.76%
ROA(5y)-2.99%
ROE(3y)-5.58%
ROE(5y)-3.51%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of CEVA (87.40%) is better than 99.09% of its industry peers.
In the last couple of years the Gross Margin of CEVA has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for CEVA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 87.4% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.67%
GM growth 5Y-0.05%
2. Health
2.1 Basic Checks
CEVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
CEVA has more shares outstanding than it did 1 year ago.
CEVA has more shares outstanding than it did 5 years ago.
There is no outstanding debt for CEVA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 8.67 indicates that CEVA is not in any danger for bankruptcy at the moment.
CEVA has a better Altman-Z score (8.67) than 74.55% of its industry peers.
CEVA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 8.67 |
ROIC/WACCN/A
WACC11.37%
2.3 Liquidity
A Current Ratio of 7.45 indicates that CEVA has no problem at all paying its short term obligations.
CEVA has a Current ratio of 7.45. This is amongst the best in the industry. CEVA outperforms 89.09% of its industry peers.
CEVA has a Quick Ratio of 7.45. This indicates that CEVA is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 7.45, CEVA belongs to the best of the industry, outperforming 91.82% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 7.45 | ||
| Quick Ratio | 7.45 |
3. Growth
3.1 Past
CEVA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 860.00%, which is quite impressive.
CEVA shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -8.60% yearly.
Looking at the last year, CEVA shows a very strong growth in Revenue. The Revenue has grown by 20.23%.
The Revenue has been growing slightly by 4.17% on average over the past years.
EPS 1Y (TTM)860%
EPS 3Y-17.12%
EPS 5Y-8.6%
EPS Q2Q%220%
Revenue 1Y (TTM)20.23%
Revenue growth 3Y-4.48%
Revenue growth 5Y4.17%
Sales Q2Q%9.85%
3.2 Future
The Earnings Per Share is expected to grow by 38.80% on average over the next years. This is a very strong growth
CEVA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.59% yearly.
EPS Next Y24.61%
EPS Next 2Y47.11%
EPS Next 3Y38.8%
EPS Next 5YN/A
Revenue Next Year4.1%
Revenue Next 2Y10.12%
Revenue Next 3Y9.59%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 44.46, which means the current valuation is very expensive for CEVA.
The rest of the industry has a similar Price/Earnings ratio as CEVA.
CEVA is valuated expensively when we compare the Price/Earnings ratio to 26.51, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 26.65, CEVA can be considered very expensive at the moment.
CEVA's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of CEVA to the average of the S&P500 Index (34.09), we can say CEVA is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 44.46 | ||
| Fwd PE | 26.65 |
4.2 Price Multiples
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CEVA is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 483.84 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CEVA does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as CEVA's earnings are expected to grow with 38.80% in the coming years.
PEG (NY)1.81
PEG (5Y)N/A
EPS Next 2Y47.11%
EPS Next 3Y38.8%
5. Dividend
5.1 Amount
No dividends for CEVA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:CEVA (8/11/2025, 3:49:01 PM)
21.34
-0.38 (-1.75%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)
Earnings (Next)
Inst Owners91.76%
Inst Owner Change0.51%
Ins Owners3.42%
Ins Owner Change27.21%
Market Cap510.45M
Analysts81.67
Price Target32.47 (52.16%)
Short Float %9.84%
Short Ratio8.51
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-8.06%
Min EPS beat(2)-15.97%
Max EPS beat(2)-0.15%
EPS beat(4)2
Avg EPS beat(4)159.87%
Min EPS beat(4)-15.97%
Max EPS beat(4)614.39%
EPS beat(8)3
Avg EPS beat(8)31.07%
EPS beat(12)5
Avg EPS beat(12)15.42%
EPS beat(16)9
Avg EPS beat(16)19%
Revenue beat(2)1
Avg Revenue beat(2)-2.93%
Min Revenue beat(2)-9.83%
Max Revenue beat(2)3.96%
Revenue beat(4)2
Avg Revenue beat(4)1.84%
Min Revenue beat(4)-9.83%
Max Revenue beat(4)13.87%
Revenue beat(8)2
Avg Revenue beat(8)-4.06%
Revenue beat(12)3
Avg Revenue beat(12)-7.15%
Revenue beat(16)7
Avg Revenue beat(16)-3.79%
PT rev (1m)-6.37%
PT rev (3m)-14.35%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-48%
EPS NY rev (1m)0%
EPS NY rev (3m)-14.07%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-7.92%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.99%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 44.46 | ||
| Fwd PE | 26.65 | ||
| P/S | 4.68 | ||
| P/FCF | 483.84 | ||
| P/OCF | 149.39 | ||
| P/B | 1.9 | ||
| P/tB | 2.44 | ||
| EV/EBITDA | N/A |
EPS(TTM)0.48
EY2.25%
EPS(NY)0.8
Fwd EY3.75%
FCF(TTM)0.04
FCFY0.21%
OCF(TTM)0.14
OCFY0.67%
SpS4.56
BVpS11.25
TBVpS8.74
PEG (NY)1.81
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.15% | ||
| ROE | -2.48% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 87.4% | ||
| FCFM | 0.97% |
ROA(3y)-4.76%
ROA(5y)-2.99%
ROE(3y)-5.58%
ROE(5y)-3.51%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.67%
GM growth 5Y-0.05%
F-Score6
Asset Turnover0.35
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 58.8% | ||
| Cap/Sales | 2.16% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 7.45 | ||
| Quick Ratio | 7.45 | ||
| Altman-Z | 8.67 |
F-Score6
WACC11.37%
ROIC/WACCN/A
Cap/Depr(3y)65%
Cap/Depr(5y)55.38%
Cap/Sales(3y)3.01%
Cap/Sales(5y)2.75%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)860%
EPS 3Y-17.12%
EPS 5Y-8.6%
EPS Q2Q%220%
EPS Next Y24.61%
EPS Next 2Y47.11%
EPS Next 3Y38.8%
EPS Next 5YN/A
Revenue 1Y (TTM)20.23%
Revenue growth 3Y-4.48%
Revenue growth 5Y4.17%
Sales Q2Q%9.85%
Revenue Next Year4.1%
Revenue Next 2Y10.12%
Revenue Next 3Y9.59%
Revenue Next 5YN/A
EBIT growth 1Y48.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year45.06%
EBIT Next 3Y100.68%
EBIT Next 5YN/A
FCF growth 1Y109.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y142.82%
OCF growth 3Y-48.76%
OCF growth 5Y-18.53%